MIT Technology Review @techreview
CRISPRoff? Yeah, that’s a (biotech) thing. Learn from Jonathan Weissman about how it affects cutting-edge research on viruses, diseases, and other genetic disorders—and how researchers are trying to manage ethical concerns and unintended consequences. #EmTechMIT — PolitiTweet.org